UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 25, 2011
Vitamin Shoppe, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 11-3664322 | |
(State or Other Jurisdiction of Incorporation or Organization) | (IRS Employer Identification No.) |
001-34507
(Commission File Number)
2101 91st Street
North Bergen, New Jersey 07047
(Addresses of Principal Executive Offices, including Zip Code)
(800) 223-1216
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 2.02 | RESULTS OF OPERATIONS & FINANCIAL CONDITIONS |
On October 26, 2011, Vitamin Shoppe, Inc. issued a press release containing its preliminary unaudited financial results for its third fiscal quarter ended September 24, 2011, and announced that it had repaid and terminated all of its outstanding term loan commitments. A copy of the press release is attached hereto as Exhibit 99.1.
| ITEM 8.01 | OTHER EVENTS |
On October 25, 2011 (the “Repayment Date”), Vitamin Shoppe, Inc. (the “Company”) and its subsidiaries, Vitamin Shoppe Industries Inc. and VS Direct, Inc. (collectively, the “Borrowers”), repaid and terminated all outstanding term loan commitments under the Amended and Restated Loan and Security Agreement, dated as of September 25, 2009, as amended January 20, 2011 by and among the Borrowers, the Company, the Lenders and Issuing Bank from time to time party thereto, and JPMorgan Chase Bank, N.A. as Administrative Agent. The repayment amount totaled $18.8 million, including accrued and unpaid interest to the Repayment Date, and was funded with available cash.
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
| (d) | Exhibits. |
Exhibit | ||
| 99.1 | Earnings release issued by Vitamin Shoppe, Inc., dated October 26, 2011. | |
This Form 8-K and the attached Exhibit are furnished to comply with Item 2.02, and Item 9.01 of Form 8-K. Neither this Form 8-K nor the attached Exhibits are to be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall this Form 8-K nor the attached Exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 (except as shall be expressly set forth by specific reference in such filing).
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Vitamin Shoppe, Inc. | ||||||
| Date: October 26, 2011 | By: | /s/ Brenda Galgano | ||||
| Name: | Brenda Galgano | |||||
| Title: | Chief Financial Officer | |||||
3